Embla Medical: Recording of Q2 2026 results presentation

EMBLAAnalyytikon kommentti21.07.2026 klo 13.16

Victor SkriverAnalyytikkoassistentti

Today, Embla Medical's CEO, Sveinn Sölvason, presented the Q2 2026 results and outlined the key drivers behind them, as well as the adjusted 2026 guidance. Focus was also directed towards advancements in innovation and how these are driving growth.

You can watch a recording of the presentation here: https://www.inderes.dk/videos/embla-medical-presentation-of-the-h1-2026-interim-report

Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Digital IR subscription agreement. /Victor Skriver, 12:16 21/07-2026

Sisäänkirjautuminen vaadittu

Tämä sisältö on näkyvissä vain sisäänkirjautuneille käyttäjille

Luo ilmainen tunnus

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Lue lisää yhtiösivulla